TEVA logo

TEVA Cash & Equivalents

Latest reported$3.66B
TEVA Quarterly Cash & Equivalents ($22.40M → $3.66B)
High-resolution chart · PNG

TEVA cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Teva Pharmaceutical Industries Limited American Depositary Shares Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
3,655,000,000
3,741,044,000
3,556,000,000
2,203,000,000
2,161,000,000
1,697,000,000
3,300,000,000
3,319,000,000
2,258,000,000
2,991,000,000
3,226,000,000
2,249,000,000
2,669,000,000
2,143,000,000
2,801,000,000
2,225,000,000
2,058,000,000
2,175,000,000
2,165,000,000
2,045,000,000
2,436,000,000
1,743,000,000
2,177,000,000
1,827,000,000
2,402,000,000
1,804,000,000
1,975,000,000
1,241,000,000
2,165,000,000
1,973,000,000
1,782,000,000
1,875,000,000
1,861,000,000
1,418,000,000
963,000,000
680,000,000
599,000,000
900,000,000
988,000,000
1,557,000,000
6,984,000,000
5,964,000,000
6,946,000,000
928,000,000
1,068,000,000
3,396,000,000
2,226,000,000
1,473,000,000
949,000,000
901,000,000
1,038,000,000
1,148,000,000
1,245,000,000
1,394,000,000
2,879,000,000
1,432,000,000
1,188,000,000
1,062,000,000
1,096,000,000
1,085,000,000
1,139,000,000
721,000,000
1,248,000,000
935,000,000
4,854,000,000
2,356,000,000
1,995,000,000
1,598,000,000
1,761,000,000
2,350,000,000
1,854,000,000
2,854,000,000
2,484,000,000
2,509,000,000
1,488,000,000
1,508,000,000
1,618,000,000
1,176,000,000
1,332,000,000
833,500,000
863,100,000
968,300,000
1,275,600,000
703,100,000
834,300,000
701,600,000
784,100,000
918,100,000
711,700,000
710,000,000
1,057,300,000
800,100,000
879,300,000
929,400,000
809,900,000
371,800,000
576,300,000
653,800,000
768,918,000
803,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.